[Cite as http://purl.org/au-research/grants/nhmrc/1143377]
Brief description The overall goal of this project is to build novel 3D biochips to culture primary human tumors with their immune cells, and to investigate patient specific responses to immune checkpoint blockade ex-vivo. Since there are currently no validated methodologies to study immunotherapy response in patient-derived cancer specimens, this proposal has the potential to provide a state-of-the art technology for the ‘personalization’ of immunotherapy.
Funding Amount $AUD 437,034.00
Funding Scheme Career Development Fellowships
RD Wright Biomedical CDF